World Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Wellness Times.

Press releases published on October 1, 2026

Oct. 1, 2026

Michigan Contact Lens Opens 1-800-DRY-EYES Center in Expanded Southfield Facility

Indeterminate GlobeNewswire

Oct. 1, 2026

Government of Saskatchewan proclaims October Health Literacy Month

Indeterminate GlobeNewswire

Oct. 1, 2026

Elevate by IMG Academy Partners with Long Beach State Athletics to Advance Leadership and Staff Development

Indeterminate GlobeNewswire

Oct. 1, 2026

Staffbase Named a Leader in the 2026 Gartner® Magic Quadrant™ for Intranet Packaged Solutions for Fourth Consecutive Year

Indeterminate GlobeNewswire

Oct. 1, 2026

HealthEdge Launches Unified AI-Powered Platform to Guarantee Financial Outcomes for Health Plans 

Indeterminate GlobeNewswire

Oct. 1, 2026

Amplio Pharma Reports Positive Early Clinical Results for NovoBioJect, Designed to Make the World's Most-Used Rheumatoid Arthritis Drug Work for More Patients

Indeterminate GlobeNewswire

Oct. 1, 2026

Zealand Pharma announces opening of new Research Hub in Cambridge, Massachusetts

Indeterminate GlobeNewswire

Oct. 1, 2026

Gain Therapeutics Presents Positive Phase 1b Open-Label Extension Data For Rexaceract Demonstrating Further Evidence of Disease-Modifying Activity Through 12 Months Administration

Indeterminate GlobeNewswire

Oct. 1, 2026

Ernexa Therapeutics CEO Corner Highlights Appointment of Dr. Robert J. Spiegel as Company Sharpens Oncology Focus and Advances ERNA-101 Toward the Clinic

Indeterminate GlobeNewswire

Oct. 1, 2026

Crohn’s and Colitis Canada Invests $1.5 Million to Advance IBD Research and Future Care

Indeterminate GlobeNewswire

Oct. 1, 2026

Crohn et Colite Canada investit 1,5 million de dollars dans la recherche sur les MII et les soins futurs

Indeterminate GlobeNewswire

Oct. 1, 2026

Challenged Athletes Foundation Receives Rings of Gold Award from U.S. Olympic & Paralympic Committee

Indeterminate GlobeNewswire

Oct. 1, 2026

BioCardia Files Revised De Novo Pre-Submission for FDA Approval of Helix™ Catheter

Indeterminate GlobeNewswire

Oct. 1, 2026

European Medicines Agency Validates PolyPid’s Marketing Authorization Application for D-PLEX₁₀₀

Indeterminate GlobeNewswire

Oct. 1, 2026

Novonesis completes acquisition of MicroBioGen, strengthening its yeast capabilities

Indeterminate GlobeNewswire

Oct. 1, 2026

Doheny Eye Institute Experts to Share Groundbreaking Insights at the American Academy of Ophthalmology 2026 Annual Meeting

Indeterminate GlobeNewswire

Oct. 1, 2026

AIM ImmunoTech Spotlights Growing Attention Around Ampligen® Pancreatic Cancer Strategy as DURIPANC Advances Toward Topline Data

Indeterminate GlobeNewswire

Oct. 1, 2026

Outlook Therapeutics Submits HCPCS Level II Application to CMS for Permanent J-Code for LYTENAVA™ (bevacizumab-vikg)

Indeterminate GlobeNewswire

Oct. 1, 2026

Chemed To Report Third Quarter 2026 Earnings October 27, Related Conference Call To Be Held On October 28

Indeterminate GlobeNewswire

Oct. 1, 2026

AONN+ and Manta Cares Partner to Equip Oncology Navigators With AI Tool Purpose-Built for Cancer Patients

Indeterminate GlobeNewswire